Stroke Motor Recovery for the Hand and Fingers
Launched by UNIVERSITY OF TORONTO · Sep 17, 2024
Trial Information
Current as of August 21, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping people recover movement in their hands and fingers after a stroke. Researchers want to compare two different rehabilitation methods to see which one helps improve finger movements more effectively. One method allows participants to use any strategies they like to reach their movement goals, while the other teaches them specific techniques to improve their movements and avoid using compensatory strategies. The trial also aims to learn who might benefit more from each method and to take brain scans to see how the brain changes with each approach, which may help develop future treatments.
To participate, individuals must be over 18 years old and have had their first stroke at least six months but less than two years ago. They should be able to move their fingers actively. Participants will visit the lab several times for assessments, complete 10 days of piano training, and undergo MRI scans to observe brain activity. This study is not yet recruiting, but it offers a chance to contribute to important research on stroke recovery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Over 18 years of age
- • Diagnosis of first time unilateral ischemic or hemorrhagic
- • Stroke occurrence: \> 6 months and \< 2 years
- • Able to perform active finger movements (Chedoke-McMaster (CM) Impairment Inventory of the Hand, Stage ≥ 3)
- Exclusion Criteria:
- • History of developmental, neurological, or major psychiatric disorders
- • Cognitive deficits (\< 23/30 Montreal Cognitive Assessment)
- • Apraxia (\<2SD mean Waterloo Apraxia test)
- • Neglect (\> 40/100, Sunnybrook Neglect Assessment Procedure)
- • Cerebellar stroke
- • Musculoskeletal injury affecting motor performance
- • Inability to sit in a chair and perform exercises for sustained periods
- • Contraindications to MRI
About University Of Toronto
The University of Toronto, a prestigious research institution, serves as a leading sponsor of clinical trials dedicated to advancing medical knowledge and improving patient care. With a commitment to innovation and excellence, the university fosters a collaborative environment that brings together multidisciplinary teams of experts in medicine, pharmacology, and public health. Through rigorous research methodologies and ethical standards, the University of Toronto aims to explore new therapies, assess treatment efficacy, and address critical health challenges, ultimately contributing to the global body of scientific knowledge and enhancing healthcare outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Laval, Quebec, Canada
Toronto, Ontario, Canada
Montreal, Quebec, Canada
Montreal, Quebec, Canada
Montréal, Quebec, Canada
Patients applied
Trial Officials
Joyce L Chen, PhD
Principal Investigator
University of Toronto: Faculty of Kinesiology & Physical Education
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported